{"id":"W2503609914","doi":"10.1093/ecco-jcc/jjw137","title":"Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease","year":2016,"lang":"en","type":"review","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Takeda Oncology; Tillotts Pharma; Bristol-Myers Squibb","keywords":"Drug development; Crohn's disease; Drug; Disease; Intensive care medicine; Pharmacokinetics; Pharmacodynamics; Dosing; Medicine; Risk analysis (engineering); Computer science; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002812598,0.0002477578,0.0005919185,0.00009943087,0.0001146806,0.00005428043,0.0001345954,0.0001183053,0.0000277129],"category_scores_gemma":[0.0001689121,0.0001832814,0.000207764,0.00002664268,0.00009502126,0.00001244297,0.0001151867,0.00009226056,5.641843e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004913189,"about_ca_system_score_gemma":0.0009489894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":9.818735e-7,"about_ca_topic_score_gemma":0.00001331728,"domain_scores_codex":[0.9987013,0.00007314717,0.0006351373,0.0002298738,0.00012163,0.0002389552],"domain_scores_gemma":[0.9989234,0.00004331719,0.0004532893,0.0001261539,0.0001612762,0.0002926275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001194564,0.00009747739,0.0001573782,0.006020611,0.0002151476,0.001189582,0.0001036394,1.424961e-7,0.000003983039,0.00009929254,0.005839471,0.9850787],"study_design_scores_gemma":[0.000878178,0.00005211651,0.02582637,0.006352046,0.0001581444,0.00007971913,0.00001844335,4.772706e-7,0.000009968476,0.00007424137,0.9662947,0.0002556008],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03270705,0.9664466,0.00004358128,0.00002349645,0.0001478637,0.0004100897,0.0001584566,0.00000178899,0.00006110661],"genre_scores_gemma":[0.006634503,0.9917003,0.0002359532,0.00006568543,0.0004185936,0.00006282583,0.00002786881,0.00002998837,0.0008242844],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9848231,"threshold_uncertainty_score":0.7473999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01522170544122095,"score_gpt":0.3079002505947149,"score_spread":0.292678545153494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}